ArticleJournal of orthopaedic case reports2026
Understanding Diagnostic Challenges in Ewing Sarcoma - A Report of Two Cases.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ewing sarcoma, along with its variants that come under the Ewing Sarcoma Family of Tumors, deals with significant diagnostic challenges due to overlapping morphological features with other undifferentiated small round cell tumors. This study explores cases where initial diagnostic uncertainty questioned our conventional diagnostic modalities, highlighting the necessity of recent advancements in molecular analysis. Case Reports: Two adolescent patients with clinical and radiological suspicion of Ewing sarcoma underwent biopsy and histopathological evaluation. Immunohistochemical panels were utilized. However, these cases demonstrated diagnostic ambiguity, necessitating further molecular testing for EWSR1 gene rearrangements - tests that were either unavailable or not pursued due to the death of the patient during follow-up, and one patient refused to do so and is in palliative chemotherapy. Usually, Ewing sarcoma presents in the first decade. These cases presented with diagnostic ambiguity because of variation in age, pattern of presentation, lymph node involvement and histopathological variation. Conclusion: Our experience brings to light the importance of incorporating molecular genetic analysis in the diagnosis of Ewing sarcoma. As the World Health Organization (WHO) classification evolves to accommodate genetically distinct Ewing-like sarcomas, it is critical to incorporate multidisciplinary consultation and the availability of molecular investigation to provide accurate diagnosis and rapid initiation of precise treatment. It is extremely important for orthopedic surgeons to be aware of these diagnostic nuances so that they can guide patients through proper diagnostic and effective treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.